Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 29, 2022
- Accession no.
- 0001415889-22-011821
- Filed
- Nov 29, 2022
- Trade date
- Nov 25-28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Nov 25, 2022 | Common Stock | SSaleDisposed | −4,252 | $266.94F2 | −$1,135,028.88 | 3,878 | Direct | |
| Nov 25, 2022 | Common Stock | SSaleDisposed | −3,674 | $267.60F3 | −$983,162.4 | 204 | Direct | |
| Nov 25, 2022 | Common Stock | SSaleDisposed | −74 | $268.53 | −$19,871.22 | 130 | Direct | |
| Nov 28, 2022 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Nov 28, 2022 | Common Stock | SSaleDisposed | −6,320 | $269.96F4 | −$1,706,147.2 | 1,810 | Direct | |
| Nov 28, 2022 | Common Stock | SSaleDisposed | −1,554 | $270.73F5 | −$420,714.42 | 256 | Direct | |
| Nov 28, 2022 | Common Stock | SSaleDisposed | −126 | $267.84F6 | −$33,747.84 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 872,000 | Direct | |
| Nov 28, 2022 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 864,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $266.30 to $267.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $267.30 to $268.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $269.288 to $270.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $270.32 to $271.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $267.41 to $268.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.